The healthcare and pharmaceutical vulnerability emerging from the new Coronavirus outbreak

Editorial highlights drug makers rely heavily on ingredients from Chinese factories, & this could cause supply problems due to the virus’ disruption of the Chinese economy. The production of medical devices may falter as well. It is clear that production backup sites are needed.


European Journal of Hospital Pharmacy